http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-014715-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
filingDate 2007-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61b947e7a05f62ccc0534011678fd221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d42ed4202ba01ecfab26b990bef94b2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b5903c804c00d9afc1fbf3e659a8b87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c02db35430c2be4e50eee8f97bc66a7
publicationDate 2011-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-014715-B1
titleOfInvention β-CRYSTAL FORM OF ARGININE SALT PERINDOPRIL, METHOD FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT HERE CONTAINS
abstract The β-crystalline form of the compound of formula (I) which is characterized by its X-ray powder diffraction pattern. Medicines
priorityDate 2006-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1354873-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0187835-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0187836-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0183439-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004000286-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ91VR8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID59272
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID478666
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID460916
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8WUW1
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID449808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565336
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID183
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24903
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12068809
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45266664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452544895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418354341
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16644
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID424957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107807
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425965134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536333
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439201
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID288001

Total number of triples: 61.